2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects

NCT01733875 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CC-220 0.03 mg
DRUG: CC-220 0.1 mg
DRUG: CC-220 0.3 mg
DRUG: CC-220 1 mg
DRUG: CC-220 2 mg
DRUG: Placebo
DRUG: CC-220
DRUG: CC-220
DRUG: CC-220

Sponsor

Celgene